--- title: "迪哲医药-U (688192.SH) — 财务报表" type: "Symbol" locale: "zh-CN" url: "https://longbridge.com/zh-CN/quote/688192.SH/norm.md" symbol: "688192.SH" name: "迪哲医药-U" parent: "https://longbridge.com/zh-CN/quote/688192.SH.md" datetime: "2026-03-10T05:58:53.355Z" locales: - [en](https://longbridge.com/en/quote/688192.SH/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/688192.SH/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/688192.SH/norm.md) --- > 支持的语言: [English](https://longbridge.com/en/quote/688192.SH/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/688192.SH/norm.md) # 迪哲医药-U (688192.SH) — 财务报表 ## 利润表 (CNY) | 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | | --- | --- | --- | --- | --- | --- | | 每股收益 | -0.3923 | -0.4496 | -0.4117 | -0.4600 | -0.6883 | | ROE | -50.92% | -52.88% | -90.03% | -725.73% | -369.66% | | 营业收入 | 214.83M | 231.30M | 195.36M | 159.64M | 21.45M | | 净利润 | -183.36M | -202.59M | -184.85M | -192.51M | -287.50M | | 营业利润 | -187.61M | -174.24M | -215.35M | -189.17M | -323.55M | | 毛利率 | 111.79% | 95.81% | 95.62% | 95.57% | 80.67% | | 净利率 | -85.35% | -87.59% | -94.62% | -120.59% | -1340.33% | | 利润含金量 | - | - | - | - | - | ## 资产负债表 (CNY) | 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | | --- | --- | --- | --- | --- | --- | | 资产与负债 | - | 2.96B | 3.22B | 1.80B | 1.72B | | 权益乘数 | - | 2.05 | 1.98 | 76.69 | 8.59 | | 每股净资产 | - | 3.14 | 3.54 | 0.0442 | 0.4639 | | 资产周转率 | - | 0.2644 | 0.2103 | 0.2611 | 0.2239 | | 现金及短投 | - | 1.93B | 2.25B | 898.76M | 839.99M | | 存货与应收 | - | 38.54M | 40.55M | 37.54M | 44.11M | | 长期投资 | - | 375.27M | 342.81M | 280.29M | 243.91M | | 净债务 | - | -864.17M | -1.07B | 531.38M | 317.39M | ## 现金流量表 (CNY) | 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | | --- | --- | --- | --- | --- | --- | | 经营现金流 | - | -159.39M | -133.00M | -131.67M | -187.22M | | 投资现金流 | - | 65.19M | -388.58M | -128.65M | 48.54M | | 融资现金流 | - | -135.47M | 1.51B | 262.62M | 260.21M | | 自由现金流 | - | -225.70M | -71.43M | -166.80M | 33.10M | | 现金流充裕率 | - | -109.08% | -28.18% | -66.65% | -225.08% | | 举债与偿债 | - | 0.0000 | 165.87M | 391.34M | 259.88M | | 资本支出 | - | -37.11M | -37.00M | -75.83M | -43.50M |